In this case study, we share how Biomapas successfully supported a pharmaceutical company during a critical vendor change, delivering a seamless transition without disruption of Pharmacovigilance (PV) and Medical Information (MI) services.
Faced with a non-negotiable one‑month deadline, the client needed a partner capable of rapidly assuming both global and local PV/MI responsibilities while maintaining full compliance. We deployed an experienced, senior safety team to manage the transition, stabilise ongoing operations, and address legacy gaps across multiple markets.
The project resulted in:
- A complete PV and MI service transition within one month
- Global and local coverage across 16 countries
- Uninterrupted compliance, quality, and operational continuity
Explore the case study below!
